| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |